Cooperative Agreement NU2GGH001937

This federal Cooperative Agreement award, provided by the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based program (CFDA 93.940), supports the South Carolina Department of Public Health (SCDPH) in implementing comprehensive efforts to prevent, diagnose, and manage HIV across South Carolina. The $1,201,336 award, effective January 1, 2025 through December 31, 2029, will fund SCDPH's activities focused on: (1) identifying and treating...

The Centers for Disease Control and Prevention (CDC) awarded a $1,120,840 Cooperative Agreement (CFDA 93.116 - Project Grants and Cooperative Agreements for Tuberculosis Control Programs) to the Alabama Department of Public Health (ADPH) to conduct comprehensive tuberculosis (TB) prevention, control, and elimination activities within the state of Alabama. The funding will support critical public health services including TB surveillance, diagnosis, treatment, contact investigations, targeted...

This $300,000 cooperative agreement from the Centers for Disease Control and Prevention under the Project Grants and Cooperative Agreements for Tuberculosis Control Programs (CFDA 93.116) will support the Florida Department of Health in strengthening civil surgeons' capacity for latent tuberculosis infection (LTBI) surveillance and treatment of status adjusters. The Florida Civil Surgeon TB Consortium, comprising the Florida Department of Health TB Control Section, Miami-Dade Health...

The South Dakota Department of Health (SD DOH) has been awarded a $319,619 Cooperative Agreement from the Centers for Disease Control and Prevention (CDC) under the HIV Prevention Activities Health Department Based (CFDA 93.940) federal grant program. The purpose of this 5-year award, effective January 1, 2025, is to assist SD DOH in preventing tuberculosis (TB) transmission and reducing the TB case rate in South Dakota. Key activities funded include supporting 1 FTE TB Program Manager, 0.5...

This Project Grant award of $1,011,348 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) supports research to understand how interactions between Mycobacterium tuberculosis (M.TB) and the human alveolar environment, particularly in people living with HIV, impact the early stages of TB infection. The key objectives are to: 1) Determine how M.TB exposure to alveolar lining fluid from people living with...

This Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under CFDA 93.116 - Project Grants and Cooperative Agreements for Tuberculosis Control Programs provides $1,307,376.00 in funding to the County of Los Angeles Department of Public Health (DPH) over a 5-year period from January 1, 2025 to December 31, 2029. The grant supports DPH's Tuberculosis Control Program (TBCP) in conducting comprehensive tuberculosis (TB) prevention, control, and elimination...

The Centers for Disease Control and Prevention (CDC) awarded a $1,391,983 Cooperative Agreement (CFDA 93.116 - Project Grants and Cooperative Agreements for Tuberculosis Control Programs) to the County of San Diego Public Health Services Division to support comprehensive tuberculosis (TB) prevention, control, and elimination efforts in San Diego County. The funding will enable the county to implement strategies focused on: 1) diagnosing and treating persons with TB disease, 2) conducting contact...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $1,350,312 to the University of California, Los Angeles (UCLA) to design and develop a rapid phenotypic drug susceptibility test, termed TRE-DST, for tuberculosis (TB). The TRE-DST system utilizes novel fluorescent trehalose probes to specifically detect live Mycobacterium tuberculosis (MTB) and determine drug...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $1,040,476 Cooperative Agreement to the Louisiana Department of Health (LDH), titled "Elimination of Tuberculosis Disease in Louisiana" under the HIV Prevention Activities Health Department Based program (CFDA 93.940). The award will support LDH's statewide Tuberculosis Control Program, which provides direction and support to 9 regional TB control programs serving Louisiana's 4.59 million residents. Key services to...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), will support a $766,877 randomized controlled trial to evaluate the efficacy of therapeutic drug monitoring (TDM) for linezolid in the treatment of rifampin-resistant tuberculosis (RR-TB). The primary objective is to determine if TDM can prevent premature discontinuation of linezolid, a critical drug for treating RR-TB. The...